January 2021

NEPHROLOGY

ACUTE KIDNEY INJURY AND COVID-19

Featuring: Anand Srivastava MD, MPH

Episode Summary

Anand Srivastava MD, MPH, discusses a recent study he co-authored, which explores AKI treated with renal replacement therapy in critically ill patients with COVID-19. Although AKI is an important sequela of COVID-19, data on AKI treated with RRT (AKI-RRT) in patients with COVID-19 are limited. This multi-center cohort study of 3099 critically ill adults with COVID-19 admitted to intensive care units at 67 hospitals across the United States identified several patient-and hospital-level risk factors for AKI-RRT and death. AKI-RRT is common among critically ill patients with COVID-19 and is associated with high mortality and persistent RRT dependence. ​
Anand Srivastava, MD, MPH, assistant professor of Medicine in the Division of Nephrology and Hypertension, was co-author of a study published in the Annals of Internal Medicine.

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​

You May Also Like